| Literature DB >> 7083461 |
L Morasca, S Marsoni, M B Pisoni, E Piazza, G Vago, W Casali, R Cogo, C Bianchi, R Scapaticci.
Abstract
Thirty-two patients with by non oat cell bronchogenic carcinoma were admitted to a protocol including Cyclophosphamide (CTX) 1,000 mg/m2 i.v. day 1, VP16-213 200 mg/m2 p.o. day 1-3, every 3 weeks. Partial remissions were seen in 2 of 27 evaluable patients; 16 of 27 showed no change. Mean survival was 36.4 weeks, median survival was 38 weeks.Entities:
Mesh：
Substances：
Year: 1982 PMID： 7083461 DOI： 10.1007/BF00254551
Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333